EXHIBIT 107

 

Calculation of Filing Fee Table

 

FORM S-1

(Form Type)

 

Zivo Bioscience, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

 

 

Security

Type

 

Security

Class

Title

 

Fee

Calculation

Rate

 

 

Amount

Registered

 

 

Proposed

Maximum

Offering

Price Per

Unit

 

 

Maximum

Aggregate

Offering

Price (1)

 

 

Fee Rate

 

 

Amount of

Registration

Fee

 

Fees to be paid

 

Equity

 

Common Stock, par value $0.001 per share(2)(3)

 

 

 457 (o)

 

 

 -

 

 

 

 -

 

 

 $ 8,000,000

 

 

 

 0.00014760

 

 

 $

 

Fees to be Paid

 

Equity

 

Common Warrants(4)

 

 

 457 (g)

 

 

 -

 

 

 

 -

 

 

 $

 

 

 

 -

 

 

 

 -

 

Fees to be Paid

 

Equity

 

Shares of Common Stock issuable upon exercise of Common Warrants(2)

 

 

 457 (o)

 

 

 -

 

 

 

 -

 

 

 $ 8,000,000

 

 

 

 0.00014760

 

 

$

 

 

Fees to be Paid

 

Equity

 

Pre-Funded Warrants(4)(3)

 

 

 457 (g)

 

 

 -

 

 

 

 -

 

 

 

 -

 

 

 

 -

 

 

 

 -

 

Fees to be Paid

 

Equity

 

Common Stock issuable upon exercise of Pre-Funded Warrants(2)(3)

 

 

 457 (o)

 

 

 -

 

 

 

 -

 

 

 

 -

 

 

 

 0.00014760

 

 

 

 -

 

 

 

 

 

Total Offering Amount

 

 

 

 

 

 

 

 

 

 

 $ 16,000,000.00

 

 

 

 

 

 

 $ 2,361.60

 

 

 

 

 

Total Fees Previously Paid

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 -

 

 

 

 

 

Total Fee Offsets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 -

 

 

 

 

 

Net Fee Due

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 $ 2,361.60

 

 

(1)

Estimated solely for the purpose of calculating the registration fee pursuant Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

(2)

Pursuant to Rule 416(a) under the Securities Act, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.

(3)

The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock, pre-funded warrants and Common Warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $8,000,000.

(4)

No fee pursuant to Rule 457(g) of the Securities Act.